These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35281761)

  • 1. Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial.
    Cartolano FC; Dias GD; Miyamoto S; Damasceno NRT
    Front Nutr; 2021; 8():767535. PubMed ID: 35281761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.
    Calabresi L; Villa B; Canavesi M; Sirtori CR; James RW; Bernini F; Franceschini G
    Metabolism; 2004 Feb; 53(2):153-8. PubMed ID: 14767865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans.
    Bønaa KH; Bjerve KS; Nordøy A
    Arterioscler Thromb; 1992 Jun; 12(6):675-81. PubMed ID: 1534256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
    Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Profile, Lipoprotein Subfractions, and Fluidity of Membranes in Children and Adolescents with Depressive Disorder: Effect of Omega-3 Fatty Acids in a Double-Blind Randomized Controlled Study.
    Katrenčíková B; Vaváková M; Waczulíková I; Oravec S; Garaiova I; Nagyová Z; Hlaváčová N; Ďuračková Z; Trebatická J
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Biochim Biophys Acta; 1997 May; 1346(1):17-24. PubMed ID: 9187298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
    Barbosa MM; Melo AL; Damasceno NR
    Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractions.
    Thomas TR; Smith BK; Donahue OM; Altena TS; James-Kracke M; Sun GY
    Metabolism; 2004 Jun; 53(6):749-54. PubMed ID: 15164323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity.
    Tani S; Matsuo R; Kawauchi K; Yagi T; Atsumi W; Hirayama A
    Heart Vessels; 2018 May; 33(5):470-480. PubMed ID: 29159568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
    Morgado N; Rigotti A; Valenzuela A
    Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
    Nissen SE; Lincoff AM; Wolski K; Ballantyne CM; Kastelein JJP; Ridker PM; Ray KK; McGuire DK; Mozaffarian D; Koenig W; Davidson MH; Garcia M; Katona BG; Himmelmann A; Loss LE; Poole M; Menon V; Nicholls SJ
    JAMA Cardiol; 2021 Aug; 6(8):910-917. PubMed ID: 33993205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
    Hall TC; Bilku DK; Neal CP; Cooke J; Fisk HL; Calder PC; Dennison AR
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep; 112():1-11. PubMed ID: 27637335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
    Maki KC; Orloff DG; Nicholls SJ; Dunbar RL; Roth EM; Curcio D; Johnson J; Kling D; Davidson MH
    Clin Ther; 2013 Sep; 35(9):1400-11.e1-3. PubMed ID: 23998969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
    JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
    Jacobson TA; Glickstein SB; Rowe JD; Soni PN
    J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.